GO:0140749 phlorizin hydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140749 phlorizin hydrolase activity is a molecular function defined as catalysis of the reaction phlorizin + H2O = beta-D-glucose + phloretin.
• The activity is best characterized as one of the two active sites of the intestinal brush-border enzyme lactase-phlorizin hydrolase (LPH), encoded by LCT.
• The two active sites of LPH are structurally and mechanistically distinct and can be differentially labeled and assigned by mechanism-based probes.
• LPH expression is transcriptionally controlled by intestinal trans-factors including NF-LPH1, HNF-1 and FREACs that interact with the LCT promoter.
• Posttranslational processing of LPH can be altered by nutritional and hormonal signals such as oral IGF-I without necessarily changing total enzyme activity.
• Altered LPH biology is most strongly linked to adult-type hypolactasia (lactose intolerance), a common condition associated with variants in the LCT regulatory region.
Description
GO:0140749 phlorizin hydrolase activity is a molecular function term describing the catalysis of the reaction phlorizin + H2O = beta-D-glucose + phloretin. This activity is not a standalone pathway but a catalytic capability that, in mammals, is experimentally assigned to one of the two active sites of the intestinal enzyme lactase-phlorizin hydrolase (LPH), the product of the LCT gene. Because phlorizin is a glucoside, the reaction is a hydrolytic cleavage of a glycosidic bond, placing the activity within the broader biology of intestinal glycoside and disaccharide handling. For researchers, GO:0140749 matters because it provides a precise, assayable functional annotation that can be separated from lactase activity even though both reside in the same polypeptide. Mechanism-based labeling studies have shown that the two active sites of LPH can be distinguished and unequivocally assigned, which makes phlorizin hydrolase activity a useful experimental readout for structure-function work on LPH. In addition, the expression of LPH is controlled by intestinal transcription factors such as NF-LPH1, HNF-1 and FREACs, linking the activity to developmental and tissue-specific gene regulation. Finally, the term is clinically relevant because LPH biology is central to lactose intolerance, a common condition in which lactase activity declines and undigested lactose causes gastrointestinal symptoms. A variant associated with adult-type hypolactasia has been identified, showing that regulatory variation in LCT can influence this enzyme system. Studying phlorizin hydrolase activity therefore connects molecular enzymology, transcriptional regulation and a widespread human phenotype.
phlorizin hydrolase activity At A Glance
| GO ID | GO:0140749 |
|---|---|
| GO term | phlorizin hydrolase activity |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Definition | Catalysis of the reaction: phlorizin + H2O = beta-D-glucose + phloretin |
| Major function | Hydrolytic cleavage of the glucoside phlorizin into beta-D-glucose and phloretin |
| Representative enzyme | Lactase-phlorizin hydrolase (LPH), encoded by LCT, in which one active site carries this activity |
| Substrate | Phlorizin, a glucoside, plus water |
| Products | beta-D-glucose and phloretin |
| Related regulation | Intestinal transcription factors NF-LPH1, HNF-1 and FREACs act on the LPH promoter |
What Is GO:0140749?
In plain terms, GO:0140749 phlorizin hydrolase activity means the ability of an enzyme to split phlorizin into beta-D-glucose and phloretin using water. The QuickGO definition states that it is the catalysis of the reaction phlorizin + H2O = beta-D-glucose + phloretin. It is a molecular_function term, meaning it describes what a gene product does at the biochemical level rather than where it acts or which pathway it belongs to. In mammals, this activity is experimentally attributed to one of the two active sites of lactase-phlorizin hydrolase, and the two sites can be differentially labeled and assigned.
Why Is phlorizin hydrolase activity Important in Cell Biology?
GO:0140749 phlorizin hydrolase activity is important because it provides a discrete, measurable enzymatic function that can be used to dissect the catalytic architecture of lactase-phlorizin hydrolase, a single polypeptide carrying two distinct active sites. This makes it a model for understanding how one protein can host multiple catalytic activities and how those activities can be independently probed. The term is also important because LPH expression is under intestinal transcriptional control by factors such as NF-LPH1, HNF-1 and FREACs, connecting the activity to tissue-specific gene regulation. Clinically, LPH biology is tied to lactose intolerance and adult-type hypolactasia, conditions with substantial population impact. Finally, nutritional and hormonal inputs such as oral IGF-I can alter LPH posttranslational processing, showing that the activity sits at the interface of enzymology, nutrition and development.
• Provides a precise molecular_function annotation for the hydrolysis of phlorizin to beta-D-glucose and phloretin.
• Allows experimental separation of phlorizin hydrolase activity from lactase activity within the same LPH polypeptide.
• Supports structure-function studies of the two active sites of lactase-phlorizin hydrolase using mechanism-based labeling.
• Links enzyme activity to intestinal transcriptional regulation by NF-LPH1, HNF-1 and FREACs.
• Connects to lactose intolerance and adult-type hypolactasia, common clinical phenotypes.
• Is relevant to developmental and nutritional regulation, since oral IGF-I alters LPH posttranslational processing.
• Serves as a functional readout for studies of intestinal brush-border enzyme maturation.
• Helps interpret variant effects in LCT regulatory regions associated with adult-type hypolactasia.
• Provides a basis for comparative studies of glycoside hydrolases and glucosylceramidase-related enzymes.
• Can be used as a marker of differentiated intestinal function in cell and animal models.
Molecular Mechanism of phlorizin hydrolase activity
Substrate recognition and binding of phlorizin
In simple terms: The enzyme must first grab the phlorizin molecule in the right orientation before it can cut it.
Phlorizin hydrolase activity acts on phlorizin, a glucoside substrate, and the reaction requires water to cleave the glycosidic bond, yielding beta-D-glucose and phloretin. In mammals, this activity is assigned to one of the two active sites of lactase-phlorizin hydrolase, and the two sites can be differentially labeled, indicating that substrate recognition is site-specific. The ability to distinguish the two sites experimentally supports the view that phlorizin binding occurs at a defined catalytic pocket rather than through nonspecific hydrolysis.
Catalytic hydrolysis of the glycosidic bond
In simple terms: Water is used to break the bond that holds glucose to the rest of the phlorizin molecule.
The catalytic step is the hydrolysis of phlorizin, described by the reaction phlorizin + H2O = beta-D-glucose + phloretin. Mechanism-based labeling studies have provided unequivocal activity assignment for the two active sites of intestinal lactase/phlorizin hydrolase, confirming that hydrolysis is an intrinsic catalytic property of the protein. This reaction is a glycoside hydrolase-type transformation, consistent with the broader family of glucosylceramidases and related enzymes discussed in the literature.
Two active sites within one polypeptide
In simple terms: The same protein contains two separate working sites, and only one of them performs the phlorizin-cutting job.
Lactase-phlorizin hydrolase is a single polypeptide that carries two active sites, and differential mechanism-based labeling has been used to assign their activities unequivocally. This dual-site architecture means that phlorizin hydrolase activity can be studied as a distinct function even though it resides in the same protein as lactase activity. The existence of two catalytically distinct sites is a key reason why GO:0140749 is annotated as a separate molecular_function term.
Transcriptional control of the enzyme carrying the activity
In simple terms: Before the enzyme can work, the cell must decide how much of it to make, and that decision is controlled by transcription factors.
Expression of lactase-phlorizin hydrolase is regulated at the promoter level by intestinal trans-factors, including NF-LPH1, which interacts with the LPH promoter and co-varies with enzymatic activity. Additional transcriptional regulation involves HNF-1 and FREACs, which have been implicated in pig LPH transcription. Because the amount of enzyme sets the ceiling for phlorizin hydrolase activity, these transcription factors are functionally upstream of GO:0140749.
Posttranslational processing and nutritional modulation
In simple terms: After the protein is made, it can be trimmed and modified, and diet or hormones can change this processing.
Oral IGF-I has been shown to alter the posttranslational processing of lactase-phlorizin hydrolase in formula-fed neonatal pigs without changing its activity, indicating that processing and catalytic output can be uncoupled. This finding is important for interpreting assays of phlorizin hydrolase activity, because changes in protein maturation do not automatically translate into changes in measured activity. It also shows that nutritional and hormonal signals can modulate the LPH system at the level of protein handling.
Key Genes Involved in GO:0140749 phlorizin hydrolase activity
The genes and proteins most directly relevant to GO:0140749 phlorizin hydrolase activity are those encoding lactase-phlorizin hydrolase and the intestinal transcription factors that control its expression.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LCT | Encodes lactase-phlorizin hydrolase, the enzyme carrying phlorizin hydrolase activity at one of its two active sites | Central target for enzymatic, structural and mutational studies of GO:0140749 |
| NF-LPH1 | Intestinal trans-factor that interacts with the LPH promoter and co-varies with enzymatic activity | Used to study transcriptional control of LPH expression |
| HNF-1 | Transcription factor involved in LPH transcriptional regulation | Relevant to intestinal gene regulation of the LPH locus |
| FREACs | Forkhead-related transcription factors implicated in LPH transcription | Used to dissect promoter regulation of LPH |
| GBA | Glucosylceramidase family member related to glycoside hydrolase biology | Provides comparative context for glycoside hydrolase mechanisms |
| GBA2 | Glucosylceramidase implicated in malignancies in mammals | Comparative model for glycoside hydrolase-disease links |
| GBA3 | Glucosylceramidase family member discussed in mammalian malignancies | Comparative context for glycoside hydrolase function |
| LCT enhancer region | Regulatory element associated with adult-type hypolactasia | Target for variant analysis linked to lactose intolerance |
| LCT promoter | Region bound by NF-LPH1 and other trans-factors | Used in reporter and binding assays for LPH regulation |
| IGF-I signaling components | Hormonal pathway that alters LPH posttranslational processing | Used to study nutritional modulation of LPH |
| Intestinal epithelial differentiation markers | Genes co-expressed with LPH in differentiated enterocytes | Used as context for LPH expression studies |
| Brush-border enzyme set | Includes LPH among intestinal digestive enzymes | Relevant to lactose intolerance pathophysiology |
| Lactose metabolism genes | Genes involved in lactose digestion and intolerance | Provide clinical context for LPH function |
| Adult-type hypolactasia locus | Genomic region associated with lactase persistence/non-persistence | Used in genetic association studies |
| Glycoside hydrolase family members | Enzymes sharing hydrolytic mechanisms with phlorizin hydrolase | Used for comparative enzymology |
| Mechanism-based probe targets | Active-site residues labeled by mechanism-based inhibitors | Used to assign the two active sites of LPH |
How Is phlorizin hydrolase activity Regulated?
Regulation of phlorizin hydrolase activity occurs at multiple levels. Transcriptionally, the LPH promoter is controlled by intestinal trans-factors including NF-LPH1, which interacts with the promoter and co-varies with enzymatic activity. HNF-1 and FREACs have also been implicated in LPH transcriptional regulation. Posttranslationally, oral IGF-I alters the processing of lactase-phlorizin hydrolase in neonatal pigs without changing its activity, showing that hormonal and nutritional inputs can modulate the protein independently of catalytic output. In addition, genetic variation in the LCT regulatory region is associated with adult-type hypolactasia, linking regulatory sequence variation to the enzyme system.
phlorizin hydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LCT | Lactose intolerance and adult-type hypolactasia | Intestinal epithelial cell models with LCT knockout or regulatory variants |
| LCT regulatory region | Adult-type hypolactasia | Reporter assays and knock-in of regulatory variants |
| NF-LPH1 | Transcriptional control of LPH expression | Promoter binding and reporter assays in intestinal cells |
| HNF-1 / FREACs | Intestinal transcriptional regulation of LPH | Knockdown or knockout in intestinal cell models |
| GBA2 | Glycosylceramidase-linked malignancies | Cancer cell models for comparative glycoside hydrolase studies |
Lactose intolerance and adult-type hypolactasia
Lactose intolerance is a common clinical condition caused by insufficient digestion of lactose, and its pathogenesis, diagnosis and treatment have been reviewed extensively. The enzyme lactase-phlorizin hydrolase is central to intestinal lactose handling, and reduced LPH function underlies the symptoms of lactose intolerance. A variant associated with adult-type hypolactasia has been identified, demonstrating that genetic regulation of the LCT locus contributes to this phenotype. Because phlorizin hydrolase activity is one of the catalytic functions of LPH, changes in LPH biology are directly relevant to interpreting this condition.
Glycoside hydrolase biology and malignancy
Glucosylceramidases, a family of glycoside hydrolases related in mechanism to phlorizin hydrolase, have been linked to malignancies in mammals. This connection places glycoside hydrolase activities within the broader context of cancer biology and provides a rationale for comparative studies. While phlorizin hydrolase activity itself is not established as a cancer driver in the cited literature, the mechanistic overlap with glucosylceramidases supports investigating related hydrolytic enzymes in disease models.
Nutritional and developmental modulation of LPH
Oral IGF-I alters the posttranslational processing of lactase-phlorizin hydrolase in formula-fed neonatal pigs without changing its activity, indicating that nutritional and hormonal factors can influence LPH biology during development. This finding is relevant to understanding how early-life nutrition may shape intestinal enzyme function. It also highlights the need to measure activity and processing separately when studying LPH-related phenotypes.
From phlorizin hydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LCT abolish phlorizin hydrolase activity? | LCT knockout intestinal epithelial cells |
| Which active-site residues are required for phlorizin hydrolysis? | Point-mutation knock-in of catalytic residues in LCT |
| How do regulatory variants affect LPH expression? | Knock-in of LCT regulatory variants with reporter readout |
| Where is LPH localized in polarized cells? | Tagged knock-in of LCT with an epitope or fluorescent tag |
| Does overexpression of LPH increase phlorizin hydrolase activity? | LCT overexpression in intestinal cell lines |
| How does nutritional signaling alter LPH processing? | Neonatal animal models with IGF-I treatment |
How to Study the phlorizin hydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phlorizin hydrolysis assay | Conversion of phlorizin to beta-D-glucose and phloretin | Assigning phlorizin hydrolase activity to LPH |
| Mechanism-based labeling | Covalent labeling of active-site residues | Distinguishing the two active sites of LPH |
| Promoter-reporter assay | Transcriptional activity of the LPH promoter | Studying NF-LPH1, HNF-1 and FREACs regulation |
| DNA-protein binding assay | Interaction of trans-factors with LPH promoter elements | Identifying NF-LPH1 binding |
| Protein processing analysis | Posttranslational maturation of LPH | Assessing effects of IGF-I on LPH processing |
| Genetic variant genotyping | Presence of adult-type hypolactasia-associated variants | Clinical and population genetics of lactose intolerance |
| Clinical lactose intolerance testing | Lactose digestion capacity in patients | Diagnosis and management of lactose intolerance |
| Comparative glycoside hydrolase assays | Hydrolytic activity of related enzymes | Contextualizing phlorizin hydrolase within glycoside hydrolase families |
Enzymatic activity assays for phlorizin hydrolysis
Direct measurement of phlorizin hydrolase activity relies on detecting the hydrolysis of phlorizin to beta-D-glucose and phloretin. Mechanism-based labeling approaches have been used to assign this activity unequivocally to one of the two active sites of lactase-phlorizin hydrolase. These assays are essential for distinguishing phlorizin hydrolase activity from lactase activity within the same protein.
Transcriptional and promoter assays
Because LPH expression is controlled by intestinal trans-factors, promoter-reporter assays and binding studies are used to study NF-LPH1, HNF-1 and FREACs. NF-LPH1 was identified as an intestinal trans-factor that interacts with the LPH promoter and co-varies with enzymatic activity. Similar approaches have been applied to pig LPH transcription to define the roles of HNF-1 and FREACs.
Protein processing and posttranslational analysis
Posttranslational processing of lactase-phlorizin hydrolase can be assessed by protein biochemical methods, as shown in studies where oral IGF-I altered processing without changing activity. Such analyses help separate changes in protein maturation from changes in catalytic output. They are particularly useful in developmental and nutritional studies of the intestinal epithelium.
Genetic and variant analysis
Genetic studies have identified a variant associated with adult-type hypolactasia, providing a model for linking sequence variation to LPH-related phenotypes. Reviews of lactose intolerance describe the diagnostic and treatment context in which such variants are interpreted. These approaches connect molecular function annotation to clinical genetics.
How CRISPR Can Be Used to Study GO:0140749 phlorizin hydrolase activity
Knockout
CRISPR knockout of LCT can be used to eliminate lactase-phlorizin hydrolase and thereby remove phlorizin hydrolase activity from a cell model, providing a clean background for functional studies. Such models help confirm that the measured activity is attributable to LPH and not to other enzymes. Knockout approaches are also useful for testing whether loss of LPH affects intestinal cell phenotypes relevant to lactose intolerance.
Point Mutation
Point mutations can be introduced into LCT to test the catalytic residues required for phlorizin hydrolysis, guided by mechanism-based labeling studies that assigned the two active sites. These models allow precise structure-function dissection of the phlorizin hydrolase active site. They are also useful for evaluating variants in regulatory regions associated with adult-type hypolactasia.
Knock-in
Knock-in of tagged LCT alleles enables tracking of LPH localization, processing and abundance in intestinal cells. Knock-in of regulatory variants can be used to study how sequence changes affect LPH expression and, consequently, phlorizin hydrolase activity. These models connect transcriptional regulation by NF-LPH1, HNF-1 and FREACs to measurable enzyme output.
Overexpression
Overexpression of LCT in intestinal cell lines can increase the amount of enzyme and provide a system for measuring phlorizin hydrolase activity above baseline. Such models are useful for biochemical characterization and for testing the effects of processing changes, including those induced by nutritional signals like IGF-I. Overexpression also supports comparative studies with related glycoside hydrolases.
How EDITGENE Supports phlorizin hydrolase activity Research
Researchers studying phlorizin hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in the catalytic function, its regulation, or its disease associations. EDITGENE provides CRISPR-based cell model services that allow precise manipulation of LCT and its regulatory network, enabling functional assignment of phlorizin hydrolase activity in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for phlorizin hydrolase activity research.
Frequently Asked Questions About phlorizin hydrolase activity
What is phlorizin hydrolase activity?
It is the catalysis of the reaction phlorizin + H2O = beta-D-glucose + phloretin, annotated as GO:0140749.
What is the GO ID for phlorizin hydrolase activity?
The GO ID is GO:0140749, and the ontology aspect is molecular_function.
Which enzyme carries phlorizin hydrolase activity?
In mammals, the activity is assigned to one of the two active sites of intestinal lactase-phlorizin hydrolase, encoded by LCT.
What reaction does phlorizin hydrolase catalyze?
It catalyzes the hydrolysis of phlorizin to beta-D-glucose and phloretin.
What genes are involved in phlorizin hydrolase activity?
LCT encodes the enzyme, while NF-LPH1, HNF-1 and FREACs regulate its transcription.
How is phlorizin hydrolase activity regulated?
It is regulated transcriptionally by intestinal trans-factors such as NF-LPH1, HNF-1 and FREACs, and posttranslationally by signals such as IGF-I.
Is phlorizin hydrolase activity related to lactose intolerance?
Yes, it is a catalytic function of lactase-phlorizin hydrolase, the enzyme central to lactose intolerance and adult-type hypolactasia.
How can I measure phlorizin hydrolase activity?
It can be measured by detecting the hydrolysis of phlorizin to beta-D-glucose and phloretin, and mechanism-based labeling can assign the active site.
Can CRISPR be used to study phlorizin hydrolase activity?
Yes, CRISPR knockout, point mutation, knock-in and overexpression of LCT can be used to study the activity and its regulation.
What diseases are linked to phlorizin hydrolase activity?
The strongest link is to lactose intolerance and adult-type hypolactasia, with broader context from glycoside hydrolase biology in malignancies.
Conclusion
GO:0140749 phlorizin hydrolase activity is a well-defined molecular function describing the hydrolysis of phlorizin to beta-D-glucose and phloretin. In mammals, it is experimentally assigned to one of the two active sites of lactase-phlorizin hydrolase, making it a valuable readout for structure-function studies of LPH. Its expression is controlled by intestinal transcription factors such as NF-LPH1, HNF-1 and FREACs, and its processing can be modulated by nutritional signals like IGF-I. Clinically, it is most closely tied to lactose intolerance and adult-type hypolactasia, a common and genetically influenced condition. For researchers, phlorizin hydrolase activity offers a precise functional endpoint that can be combined with CRISPR-based models to dissect catalysis, regulation and disease relevance. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression and library-screening services tailored to LCT and its regulatory network.
References
- 1. Catanzaro R et al.. 2021. Lactose intolerance: An update on its pathogenesis, diagnosis, and treatment.. Nutr Res 89:23-34 PMID: 33887513
- 2. Enattah NS et al.. 2002. Identification of a variant associated with adult-type hypolactasia.. Nat Genet 30(2):233-7 PMID: 11788828
- 3. Büller HA et al.. 1990. Lactose intolerance.. Annu Rev Med 41:141-8 PMID: 2109963
- 4. Arribas JC et al.. 2000. Differential mechanism-based labeling and unequivocal activity assignment of the two active sites of intestinal lactase/phlorizin hydrolase.. Eur J Biochem 267(24):6996-7005 PMID: 11106409
- 5. Troelsen JT et al.. 1992. A novel intestinal trans-factor (NF-LPH1) interacts with the lactase-phlorizin hydrolase promoter and co-varies with the enzymatic activity.. J Biol Chem 267(28):20407-11 PMID: 1400359
- 6. Astudillo L et al.. 2016. Glucosylceramidases and malignancies in mammals.. Biochimie 125:267-80 PMID: 26582417
- 7. Burrin DG et al.. 2001. Oral IGF-I alters the posttranslational processing but not the activity of lactase-phlorizin hydrolase in formula-fed neonatal pigs.. J Nutr 131(9):2235-41 PMID: 11533260
- 8. Spodsberg N et al.. 1999. Transcriptional regulation of pig lactase-phlorizin hydrolase: involvement of HNF-1 and FREACs.. Gastroenterology 116(4):842-54 PMID: 10092306
